Regulation of biotech and manufacturing deals in the US could prompt foreign companies to seek alternative targets elsewhere.
Roche has received US FDA approval of two wAMD therapies, but one was recently recalled due to a manufacturing defect.
Governmental bodies should use Australia as a case study and make decisions now to keep healthcare systems from being overwhelmed.
The offer comes after Myovant and Pfizer received FDA expanded approval of Myfembree for moderate to severe endometriosis pain.
Insulin icodec has achieved significant results in all of its clinical trials.
Get industry leading news, data and analysis delivered to your inbox
There is potential for CAR-T therapy products to penetrate the CLL market due to unmet needs among end-stage refractory patients.
Mounjaro has overwhelming potential to be favoured among many patients and clinicians alike if it is approved for obesity.
The approvals represent crucial milestones for bluebird bio, the gene therapy field, and patients with rare genetic diseases.
Both Sandoz and Novartis are internationally renowned pharma companies, with a total of 34 production facilities worldwide.
As late-stage therapies for DES progress through clinical development, physicians and patients grow increasingly excited.